
Blood Pressure, Circulation Supplement to Enter Clinical Trial
Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial.
Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial to study its safety and efficacy in lowering blood pressure and improving blood circulation in mildly hypertensive subjects.
The company says that the trial will be a double-blind, randomized, placebo-controlled, parallel-group, multicenter study. It will be performed by contract research organization Vedic Lifesciences (Redwood Shores, CA).
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





